Furthermore, inhibition of CDK4/6 kinase activity using PD0332991 leads to inhibition of cell cycle progression and accumulation in the Go/G1cell cycle phase in T-ALL primary samples, triggers apoptosis, and blocks progression of leukemia in a mouse model of T-ALL (Sawai et al., 2012). Here, CDK4 is linked to leukemia.